{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T08:29:19Z","timestamp":1786609759912,"version":"build-2736575974"},"reference-count":84,"publisher":"IMR Press","issue":"7","license":[{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Biosci. (Landmark Ed)"],"abstract":"<jats:p>Neutrophil extracellular traps (NETs) have emerged as important mediators at the interface of innate immunity, thrombosis, and vascular remodeling. Aortic aneurysms and cerebrovascular diseases are now recognized as prototypical NET-driven conditions in which dysregulated immunothrombosis accelerates wall degeneration, promotes thrombus formation, and exacerbates tissue damage. This narrative review synthesizes current evidence on NET biology in the context of abdominal and thoracic aortic aneurysms, acute aortic syndromes, ischemic stroke, and intracerebral hemorrhage. First, we summarize the molecular mechanisms of NET formation, regulation, and clearance, outlining how NETs shape the immunothrombotic niche in aneurysm thrombi and the cerebral vasculature. Following this, experimental and clinical data on circulating and tissue NET markers are examined in relation to disease presence, lesion instability, hematoma expansion, and functional outcome, thereby highlighting their potential as diagnostic and prognostic biomarkers. Thereafter, pharmacological strategies that either inhibit NET formation or enhance NET degradation are discussed. We then examine how multilayered flow modulators, biodegradable scaffolds, and bioinspired stent coatings can modulate NET responses at the blood-device interface. Finally, we explore the emerging roles of multi-omics profiling, molecular imaging, artificial intelligence (AI)-based analyses in integrating NET-related signals into personalized risk prediction, device selection, and treatment monitoring. Collectively, these findings position NETs as central targets for biomarker development, immunomodulatory therapy, and immunobioengineered vascular devices. NET-informed precision management of aortic and cerebrovascular diseases is therefore a key area for further research.<\/jats:p>","DOI":"10.31083\/fbl48293","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T12:17:49Z","timestamp":1785413869000},"source":"Crossref","is-referenced-by-count":0,"title":["Neutrophil Extracellular Traps in Aortic and Cerebrovascular Diseases: Biomarkers, Immunomodulation, and Device-Related Strategies"],"prefix":"10.31083","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1382-0262","authenticated-orcid":true,"given":"Rasit","family":"Dinc","sequence":"first","affiliation":[{"name":"INVAMED Medical Innovation Institute, New York, NY 10007, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2726-7990","authenticated-orcid":true,"given":"Nurittin","family":"Ardic","sequence":"additional","affiliation":[{"name":"Med-International UK Health Agency Ltd., CV11 6LT Warwickshire, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"16242","published-online":{"date-parts":[[2026,7,27]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Kwan JY, Dar T, Davies H, Stocco F, Scott DJ, Bailey MA, et al. Cardiovascular morbidity, mortality and risk management in patients with abdominal aortic aneurysms. Journal of Vascular Societies Great Britain and Ireland. 2024; 4: 18\u201324.","DOI":"10.54522\/jvsgbi.2024.152"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Allinson KS. Deaths related to stroke and cerebrovascular disease. Diagnostic Histopathology. 2025; 31: 22\u201331.","DOI":"10.1016\/j.mpdhp.2024.10.005"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Stark K, Massberg S. Interplay between inflammation and thrombosis in cardiovascular pathology. Nature Reviews. Cardiology. 2021; 18: 666\u2013682.","DOI":"10.1038\/s41569-021-00552-1"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Mutua V, Gershwin LJ. A Review of Neutrophil Extracellular Traps (NETs) in Disease: Potential Anti-NETs Therapeutics. Clinical Reviews in Allergy & Immunology. 2021; 61: 194\u2013211.","DOI":"10.1007\/s12016-020-08804-7"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Papayannopoulos V. Neutrophil extracellular traps in immunity and disease. Nature Reviews. Immunology. 2018; 18: 134\u2013147.","DOI":"10.1038\/nri.2017.105"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Ibrahim N, Eilenberg W, Neumayer C, Brostjan C. Neutrophil Extracellular Traps in Cardiovascular and Aortic Disease: A Narrative Review on Molecular Mechanisms and Therapeutic Targeting. International Journal of Molecular Sciences. 2024; 25: 3983.","DOI":"10.3390\/ijms25073983"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"He W, Wu Z, Liu Y, Ye Z. Neutrophil extracellular traps in ischemic stroke: mechanisms, clinical implications, and therapeutic potential. Frontiers in Neurology. 2025; 16: 1641985.","DOI":"10.3389\/fneur.2025.1641985"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Denorme F, Portier I, Rustad JL, Cody MJ, de Araujo CV, Hoki C, et al. Neutrophil extracellular traps regulate ischemic stroke brain injury. The Journal of Clinical Investigation. 2022; 132: e154225.","DOI":"10.1172\/JCI154225"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Ma Y, Zhang J, Qi Y, Lu Y, Dong Y, Hu D. Neutrophil Extracellular Traps in Cardiovascular Diseases: Pathological Roles and Therapeutic Implications. Biomolecules. 2025; 15: 1263.","DOI":"10.3390\/biom15091263"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Mengozzi L, Barison I, Mal\u00fd M, Lorenzoni G, Fedrigo M, Castellani C, et al. Neutrophil Extracellular Traps and Thrombolysis Resistance: New Insights for Targeting Therapies. Stroke. 2024; 55: 963\u2013971.","DOI":"10.1161\/STROKEAHA.123.045225"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Raghavan P, Nwagwu C, Finbloom JA, Desai TA. Engineering the NET-biomaterial interface to treat disease. Current Opinion in Biomedical Engineering. 2025; 36: 100629.","DOI":"10.1016\/j.cobme.2025.100629"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Seol SI, Oh SA, Davaanyam D, Lee JK. Blocking peptidyl arginine deiminase 4 confers neuroprotective effect in the post-ischemic brain through both NETosis-dependent and -independent mechanisms. Acta Neuropathologica Communications. 2025; 13: 33.","DOI":"10.1186\/s40478-025-01951-y"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Farkas \u00c1Z, Farkas VJ, Gubucz I, Szab\u00f3 L, B\u00e1lint K, Tenekedjiev K, et al. Neutrophil extracellular traps in thrombi retrieved during interventional treatment of ischemic arterial diseases. Thrombosis Research. 2019; 175: 46\u201352.","DOI":"10.1016\/j.thromres.2019.01.006"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Wang H, Kim SJ, Lei Y, Wang S, Wang H, Huang H, et al. Neutrophil extracellular traps in homeostasis and disease. Signal Transduction and Targeted Therapy. 2024; 9: 235.","DOI":"10.1038\/s41392-024-01933-x"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Hong JK, Waterhouse A. Bioinspired Approaches to Engineer Antithrombogenic Medical Devices for Vascular Intervention. Arteriosclerosis, Thrombosis, and Vascular Biology. 2023; 43: 797\u2013812.","DOI":"10.1161\/ATVBAHA.122.318238"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Raffort J, Adam C, Carrier M, Ballaith A, Coscas R, Jean-Baptiste E, et al. Artificial intelligence in abdominal aortic aneurysm. Journal of Vascular Surgery. 2020; 72: 321\u2013333.e1.","DOI":"10.1016\/j.jvs.2019.12.026"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Dinc R, Adic N. Molecular and Cellular Mechanisms of Neutrophil Extracellular Traps in Cardiovascular Diseases: From NET Formation to Mechanistic Therapeutic Targeting. Biocell. 2026; 50: 5.","DOI":"10.32604\/biocell.2025.072337"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Liang LM, Chen X, Deng Y. Neutrophil extracellular traps in cardiovascular disease: a bibliometric analysis (2005-2024). Naunyn-Schmiedeberg's Archives of Pharmacology. 2026; 399: 1609\u20131624.","DOI":"10.1007\/s00210-025-04507-y"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Adamidis PS, Pantazi D, Moschonas IC, Liberopoulos E, Tselepis AD. Neutrophil Extracellular Traps (NETs) and Atherosclerosis: Does Hypolipidemic Treatment Have an Effect? Journal of Cardiovascular Development and Disease. 2024; 11: 72.","DOI":"10.3390\/jcdd11030072"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Kang L, Yu H, Yang X, Zhu Y, Bai X, Wang R, et al. Neutrophil extracellular traps released by neutrophils impair revascularization and vascular remodeling after stroke. Nature Communications. 2020; 11: 2488.","DOI":"10.1038\/s41467-020-16191-y"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Boeltz S, Amini P, Anders HJ, Andrade F, Bilyy R, Chatfield S, et al. To NET or not to NET:current opinions and state of the science regarding the formation of neutrophil extracellular traps. Cell Death and Differentiation. 2019; 26: 395\u2013408.","DOI":"10.1038\/s41418-018-0261-x"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Natorska J, Z\u0105bczyk M, Undas A. Neutrophil extracellular traps (NETs) in cardiovascular diseases: From molecular mechanisms to therapeutic interventions. Kardiologia Polska. 2023; 81: 1205\u20131216.","DOI":"10.33963\/v.kp.98520"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Zhang S, Jin Z, Jiang L, Zhang Y, Wu T, Xu P, et al. Unveiling the inflammatory messengers after intracerebral hemorrhage: the crosstalk between peripheral NETs and microglia. Frontiers in Immunology. 2025; 16: 1643524.","DOI":"10.3389\/fimmu.2025.1643524"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Jim\u00e9nez-Alc\u00e1zar M, Rangaswamy C, Panda R, Bitterling J, Simsek YJ, Long AT, et al. Host DNases prevent vascular occlusion by neutrophil extracellular traps. Science (New York, N.Y.). 2017; 358: 1202\u20131206.","DOI":"10.1126\/science.aam8897"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Hakkim A, Fuchs TA, Martinez NE, Hess S, Prinz H, Zychlinsky A, et al. Activation of the Raf-MEK-ERK pathway is required for neutrophil extracellular trap formation. Nature Chemical Biology. 2011; 7: 75\u201377.","DOI":"10.1038\/nchembio.496"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Farrera C, Fadeel B. Macrophage clearance of neutrophil extracellular traps is a silent process. Journal of Immunology (Baltimore, Md.: 1950). 2013; 191: 2647\u20132656.","DOI":"10.4049\/jimmunol.1300436"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Manda-Handzlik A, Cieloch A, Ku\u017amicka W, Mroczek A, Stelmaszczyk-Emmel A, Demkow U, et al. Secretomes of M1 and M2 macrophages decrease the release of neutrophil extracellular traps. Scientific Reports. 2023; 13: 15633.","DOI":"10.1038\/s41598-023-42167-1"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Shi Y, Wu D, Wang Y, Shao Y, Zeng F, Zhou D, et al. Treg and neutrophil extracellular trap interaction contributes to the development of immunosuppression in sepsis. JCI Insight. 2024; 9: e180132.","DOI":"10.1172\/jci.insight.180132"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Meher AK, Spinosa M, Davis JP, Pope N, Laubach VE, Su G, et al. Novel Role of IL (Interleukin)-1\u03b2 in Neutrophil Extracellular Trap Formation and Abdominal Aortic Aneurysms. Arteriosclerosis, Thrombosis, and Vascular Biology. 2018; 38: 843\u2013853.","DOI":"10.1161\/ATVBAHA.117.309897"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Dhawan UK, Vartak T, Englert H, Russo S, Vasconcellos LRC, Singhal A, et al. Macrophage DNases Limit Neutrophil Extracellular Trap-Mediated Defective Efferocytosis in Atherosclerosis. Circulation Research. 2025; 137: 1255\u20131275.","DOI":"10.1161\/CIRCRESAHA.125.326353"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Liu Y, Lin W, Bai Z, Ge Y, Xiao Y, Zhu F, et al. Lcn2 from neutrophil extracellular traps induces astrogliosis and post-stroke emotional disorders. Neuron. 2025; 113: 4199\u20134216.e8.","DOI":"10.1016\/j.neuron.2025.09.018"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"Roh JS, Sohn DH. Damage-Associated Molecular Patterns in Inflammatory Diseases. Immune Network. 2018; 18: e27.","DOI":"10.4110\/in.2018.18.e27"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"Yang S, Chen L, Wang Z, Chen J, Ni Q, Guo X, et al. Neutrophil extracellular traps induce abdominal aortic aneurysm formation by promoting the synthetic and proinflammatory smooth muscle cell phenotype via Hippo-YAP pathway. Translational Research: the Journal of Laboratory and Clinical Medicine. 2023; 255: 85\u201396.","DOI":"10.1016\/j.trsl.2022.11.010"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"Dihlmann S, Kaduk C, Passek KH, Spieler A, B\u00f6ckler D, Peters AS. Exploring circulating cell-free DNA as a biomarker and as an inducer of AIM2-inflammasome-mediated inflammation in patients with abdominal aortic aneurysm. Scientific Reports. 2025; 15: 20196.","DOI":"10.1038\/s41598-025-06220-5"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"Ngo AT, Gollomp K. Building a better NET: Neutrophil extracellular trap targeted therapeutics in the treatment of infectious and inflammatory disorders. Research and Practice in Thrombosis and Haemostasis. 2022; 6: e12808.","DOI":"10.1002\/rth2.12808"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"Brandau A, Ibrahim N, Klopf J, Hayden H, Ozsvar-Kozma M, Afonyushkin T, et al. Association of Lipoproteins with Neutrophil Extracellular Traps in Patients with Abdominal Aortic Aneurysm. Biomedicines. 2022; 10: 217.","DOI":"10.3390\/biomedicines10020217"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"Wei M, Wang X, Song Y, Zhu D, Qi D, Jiao S, et al. Inhibition of Peptidyl Arginine Deiminase 4-Dependent Neutrophil Extracellular Trap Formation Reduces Angiotensin II-Induced Abdominal Aortic Aneurysm Rupture in Mice. Frontiers in Cardiovascular Medicine. 2021; 8: 676612.","DOI":"10.3389\/fcvm.2021.676612"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"Tian Z, Zhang Y, Zheng Z, Zhang M, Zhang T, Jin J, et al. Gut microbiome dysbiosis contributes to abdominal aortic aneurysm by promoting neutrophil extracellular trap formation. Cell Host & Microbe. 2022; 30: 1450\u20131463.e8.","DOI":"10.1016\/j.chom.2022.09.004"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"Gafitanu C, Ondracek AS, Panzenboeck A, Artner T, Werner P, Andreas M, et al. Neutrophil extracellular traps, deoxyribonuclease and fibrosis in thoracic aortic aneurysm. European Heart Journal. 2024; 45: ehae666.3869.","DOI":"10.1093\/eurheartj\/ehae666.3869"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"Yang S, Xiao Y, Du Y, Chen J, Ni Q, Guo X, et al. Diagnostic and Prognostic Value of Neutrophil Extracellular Trap Levels in Patients With Acute Aortic Dissection. Frontiers in Cardiovascular Medicine. 2022; 8: 683445.","DOI":"10.3389\/fcvm.2021.683445"},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"Plana E, Oto J, Medina P, Fern\u00e1ndez-Pardo \u00c1, Miralles M. Novel contributions of neutrophils in the pathogenesis of abdominal aortic aneurysm, the role of neutrophil extracellular traps: A systematic review. Thrombosis Research. 2020; 194: 200\u2013208.","DOI":"10.1016\/j.thromres.2020.07.039"},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"Dinc R, Ardic N. Role of Potential Biomarkers in Aortic Aneurysms: Does It Hold Promise for Clinical Decision Making? Annals of Vascular Surgery. 2025; 110: 349\u2013352.","DOI":"10.1016\/j.avsg.2024.07.128"},{"key":"ref43","doi-asserted-by":"publisher","unstructured":"Murphy SJ, Werring DJ. Stroke: causes and clinical features. Medicine (Abingdon, England: UK Ed.). 2020; 48: 561\u2013566.","DOI":"10.1016\/j.mpmed.2020.06.002"},{"key":"ref44","doi-asserted-by":"publisher","unstructured":"Akkipeddi SMK, Rahmani R, Ellens NR, Kohli GS, Houk C, Schartz DA, et al. Histone content, and thus DNA content, is associated with differential in vitro lysis of acute ischemic stroke clots. Journal of Thrombosis and Haemostasis: JTH. 2024; 22: 1410\u20131420.","DOI":"10.1016\/j.jtha.2024.01.013"},{"key":"ref45","doi-asserted-by":"publisher","unstructured":"Liaptsi E, Merkouris E, Polatidou E, Tsiptsios D, Gkantzios A, Kokkotis C, et al. Targeting Neutrophil Extracellular Traps for Stroke Prognosis: A Promising Path. Neurology International. 2023; 15: 1212\u20131226.","DOI":"10.3390\/neurolint15040076"},{"key":"ref46","doi-asserted-by":"publisher","unstructured":"Tang J, Yue J, Tao Y, Zhao G, Yi X, Zhang M, et al. Neutrophil Extracellular Traps Induce Brain Edema Around Intracerebral Hematoma via ERK-Mediated Regulation of MMP9 and AQP4. Translational Stroke Research. 2025; 16: 1461\u20131473.","DOI":"10.1007\/s12975-024-01318-w"},{"key":"ref47","doi-asserted-by":"publisher","unstructured":"Ouyang JF, Mishra K, Xie Y, Park H, Huang KY, Petretto E, et al. Systems level identification of a matrisome-associated macrophage polarisation state in multi-organ fibrosis. Elife. 2023; 12: e85530.","DOI":"10.7554\/eLife.85530"},{"key":"ref48","doi-asserted-by":"publisher","unstructured":"Zeineddine HA, Hong SH, Peesh P, Dienel A, Torres K, Thankamani Pandit P, et al. Neutrophils and Neutrophil Extracellular Traps Cause Vascular Occlusion and Delayed Cerebral Ischemia After Subarachnoid Hemorrhage in Mice. Arteriosclerosis, Thrombosis, and Vascular Biology. 2024; 44: 635\u2013652.","DOI":"10.1161\/ATVBAHA.123.320224"},{"key":"ref49","doi-asserted-by":"publisher","unstructured":"Th\u00e5lin C, Hisada Y, Lundstr\u00f6m S, Mackman N, Wall\u00e9n H. Neutrophil Extracellular Traps: Villains and Targets in Arterial, Venous, and Cancer-Associated Thrombosis. Arteriosclerosis, Thrombosis, and Vascular Biology. 2019; 39: 1724\u20131738.","DOI":"10.1161\/ATVBAHA.119.312463"},{"key":"ref50","doi-asserted-by":"publisher","unstructured":"Hayden H, Ibrahim N, Klopf J, Zagrapan B, Mauracher LM, Hell L, et al. ELISA detection of MPO-DNA complexes in human plasma is error-prone and yields limited information on neutrophil extracellular traps formed in vivo. PloS One. 2021; 16: e0250265.","DOI":"10.1371\/journal.pone.0250265"},{"key":"ref51","doi-asserted-by":"publisher","unstructured":"de Diego C, Lasierra AB, L\u00f3pez-Vergara L, Torralba L, Ruiz de Gopegui P, Lahoz R, et al. What is the actual relationship between neutrophil extracellular traps and COVID-19 severity? A longitudinal study. Respiratory Research. 2024; 25: 48.","DOI":"10.1186\/s12931-023-02650-9"},{"key":"ref52","doi-asserted-by":"publisher","unstructured":"D\u00f6ring Y, Libby P, Soehnlein O. Neutrophil Extracellular Traps Participate in Cardiovascular Diseases: Recent Experimental and Clinical Insights. Circulation Research. 2020; 126: 1228\u20131241.","DOI":"10.1161\/CIRCRESAHA.120.315931"},{"key":"ref53","doi-asserted-by":"publisher","unstructured":"Albano D, Rizzo A, Guarneri A, Leccisotti L, Rodella C, Treglia G. Emerging PET-radiotracers in cardiovascular, neuro-inflammation, lung and rheumatological diseases: a narrative review. EJNMMI Reports. 2025; 9: 28.","DOI":"10.1186\/s41824-025-00263-7"},{"key":"ref54","doi-asserted-by":"publisher","unstructured":"Tong W, Hui H, Shang W, Zhang Y, Tian F, Ma Q, et al. Highly sensitive magnetic particle imaging of vulnerable atherosclerotic plaque with active myeloperoxidase-targeted nanoparticles. Theranostics. 2021; 11: 506\u2013521.","DOI":"10.7150\/thno.49812"},{"key":"ref55","doi-asserted-by":"publisher","unstructured":"Lareyre F, Chaudhuri A, Raffort J. Artificial Intelligence Based Methods to Enhance Analysis of Non-Contrast Computed Tomography in Patients with Aortic Aneurysm. European Journal of Vascular and Endovascular Surgery: the Official Journal of the European Society for Vascular Surgery. 2024; 68: 418.","DOI":"10.1016\/j.ejvs.2024.05.046"},{"key":"ref56","doi-asserted-by":"publisher","unstructured":"Guo J, Lareyre F, Lee R, Teraa M, Delingette H, Raffort J. Artificial Intelligence and Machine Learning for Risk Prediction of Abdominal Aortic Aneurysm Growth and Rupture. Angiology. 2025.  (online ahead of print)","DOI":"10.1177\/00033197251379127"},{"key":"ref57","doi-asserted-by":"publisher","unstructured":"Dinc R, Ardic N. AI-driven decision making for intravascular device selection in aortic disease. Current insights and prospects. Frontiers in Cardiovascular Medicine. 2025; 12: 1585299.","DOI":"10.3389\/fcvm.2025.1585299"},{"key":"ref58","doi-asserted-by":"publisher","unstructured":"Ardic N, Dinc R. Emerging trends in multi-modal artificial intelligence for clinical decision support: A narrative review. Health Informatics Journal. 2025; 31: 14604582251366141.","DOI":"10.1177\/14604582251366141"},{"key":"ref59","doi-asserted-by":"publisher","unstructured":"Rieke N, Hancox J, Li W, Milletar\u00ec F, Roth HR, Albarqouni S, et al. The future of digital health with federated learning. NPJ Digital Medicine. 2020; 3: 119.","DOI":"10.1038\/s41746-020-00323-1"},{"key":"ref60","doi-asserted-by":"publisher","unstructured":"Lekadir K, Quaglio G, Garmendia AT, Gallin C. Artificial intelligence in healthcare: Applications, risks, and ethical and societal impacts. European Parliament. 2022.","DOI":"10.2861\/568473"},{"key":"ref61","doi-asserted-by":"publisher","unstructured":"Zeng H, Fu X, Cai J, Sun C, Yu M, Peng Y, et al. Neutrophil Extracellular Traps may be a Potential Target for Treating Early Brain Injury in Subarachnoid Hemorrhage. Translational Stroke Research. 2022; 13: 112\u2013131.","DOI":"10.1007\/s12975-021-00909-1"},{"key":"ref62","doi-asserted-by":"publisher","unstructured":"Di G, V\u00e1zquez-Reyes S, D\u00edaz B, Pe\u00f1a-Martinez C, Garc\u00eda-Culebras A, Cuartero MI, et al. Daytime DNase-I Administration Protects Mice From Ischemic Stroke Without Inducing Bleeding or tPA-Induced Hemorrhagic Transformation, Even With Aspirin Pretreatment. Stroke. 2025; 56: 527\u2013532.","DOI":"10.1161\/STROKEAHA.124.049961"},{"key":"ref63","doi-asserted-by":"publisher","unstructured":"Pe\u00f1a-Mart\u00ednez C, Dur\u00e1n-Laforet V, Garc\u00eda-Culebras A, Ostos F, Hern\u00e1ndez-Jim\u00e9nez M, Bravo-Ferrer I, et al. Pharmacological Modulation of Neutrophil Extracellular Traps Reverses Thrombotic Stroke tPA (Tissue-Type Plasminogen Activator) Resistance. Stroke. 2019; 50: 3228\u20133237.","DOI":"10.1161\/STROKEAHA.119.026848"},{"key":"ref64","unstructured":"Campell BCV and trial group. Improving Early Reperfusion With Adjuvant Dornase Alfa in Large Vessel Ischemic Stroke (EXTEND-IA DNase). 2026. Available at: https:\/\/clinicaltrials.gov\/study\/NCT05203224 (Accessed: 6 July 2026)."},{"key":"ref65","unstructured":"ClinicalTrials.gov. Reduction of SystemiC Inflammation After Ischemic Stroke by Intravenous DNase Administration (ReSCInD). 2024. Available at: https:\/\/clinicaltrials.eu\/trial\/study-on-reducing-inflammation-in-acute-ischemic-stroke-patients-using-dornase-alfa-and-sodium-chloride\/ (Accessed: 6 July 2026). https:\/\/clinicaltrials.gov\/study\/NCT05880524"},{"key":"ref66","doi-asserted-by":"publisher","unstructured":"Fang H, Bo Y, Hao Z, Mang G, Jin J, Wang H. A promising frontier: targeting NETs for stroke treatment breakthroughs. Cell Communication and Signaling: CCS. 2024; 22: 238.","DOI":"10.1186\/s12964-024-01563-4"},{"key":"ref67","doi-asserted-by":"publisher","unstructured":"Chen N, Li M, Wu H, Qin Y, Wang J, Xu K, et al. An extracellular matrix-mimetic coating with dual bionics for cardiovascular stents. Regenerative Biomaterials. 2023; 10: rbad055.","DOI":"10.1093\/rb\/rbad055"},{"key":"ref68","doi-asserted-by":"publisher","unstructured":"Labarrere CA, Dabiri AE, Kassab GS. Thrombogenic and Inflammatory Reactions to Biomaterials in Medical Devices. Frontiers in Bioengineering and Biotechnology. 2020; 8: 123.","DOI":"10.3389\/fbioe.2020.00123"},{"key":"ref69","doi-asserted-by":"publisher","unstructured":"Staessens S, Moussa MD, Pierache A, Rauch A, Rousse N, Boulleaux E, et al. Thrombus formation during ECMO: Insights from a detailed histological analysis of thrombus composition. Journal of Thrombosis and Haemostasis: JTH. 2022; 20: 2058\u20132069.","DOI":"10.1111\/jth.15784"},{"key":"ref70","doi-asserted-by":"publisher","unstructured":"Dinc R, Ekingen E. Role of multilayer flow modulator stents in the treatment of arterial aneurysms. Therapeutic Advances in Cardiovascular Disease. 2024; 18: 17539447241283736.","DOI":"10.1177\/17539447241283736"},{"key":"ref71","doi-asserted-by":"publisher","unstructured":"Dinc R, Ekingen E. Biodegradable Stents in the Treatment of Arterial Stenosis. Journal of Clinical Medicine. 2025; 14: 532.","DOI":"10.3390\/jcm14020532"},{"key":"ref72","doi-asserted-by":"publisher","unstructured":"Dinc R. Artificial Intelligence in Drug-Coated Cardiovascular Devices: A Narrative Review. Reviews in Cardiovascular Medicine. 2025; 26: 40892.","DOI":"10.31083\/RCM40892"},{"key":"ref73","doi-asserted-by":"publisher","unstructured":"Meara CHO, Coupland LA, Kordbacheh F, Quah BJC, Chang CW, Simon Davis DA, et al. Neutralizing the pathological effects of extracellular histones with small polyanions. Nature Communications. 2020; 11: 6408.","DOI":"10.1038\/s41467-020-20231-y"},{"key":"ref74","doi-asserted-by":"publisher","unstructured":"Hogwood J, Pitchford S, Mulloy B, Page C, Gray E. Heparin and non-anticoagulant heparin attenuate histone-induced inflammatory responses in whole blood. PloS One. 2020; 15: e0233644.","DOI":"10.1371\/journal.pone.0233644"},{"key":"ref75","doi-asserted-by":"publisher","unstructured":"Hosseinnejad A, Ludwig N, Wienkamp AK, Rimal R, Bleilevens C, Rossaint R, et al. DNase I functional microgels for neutrophil extracellular trap disruption. Biomaterials Science. 2021; 10: 85\u201399.","DOI":"10.1039\/d1bm01591e"},{"key":"ref76","doi-asserted-by":"publisher","unstructured":"Zalghout S, Martinod K. Therapeutic potential of DNases in immunothrombosis: promising succor or uncertain future? Journal of Thrombosis and Haemostasis: JTH. 2025; 23: 760\u2013778.","DOI":"10.1016\/j.jtha.2024.11.028"},{"key":"ref77","doi-asserted-by":"publisher","unstructured":"Kohse M, Witzdam L, Jakob F, Boes A, Mescheder H, Day R, et al. Bioinspired active hemocompatible coating systems for mechanical circulatory support devices: when engineering meets nano and molecular technology. Procedia CIRP. 2024; 125: 60\u201365.","DOI":"10.1016\/j.procir.2024.08.011"},{"key":"ref78","doi-asserted-by":"publisher","unstructured":"Zhong JX, Raghavan P, Desai TA. Harnessing Biomaterials for Immunomodulatory-Driven Tissue Engineering. Regenerative Engineering and Translational Medicine. 2023; 9: 224\u2013239.","DOI":"10.1007\/s40883-022-00279-6"},{"key":"ref79","doi-asserted-by":"publisher","unstructured":"Xie X, Shi Q, Wu P, Zhang X, Kambara H, Su J, et al. Single-cell transcriptome profiling reveals neutrophil heterogeneity in homeostasis and infection. Nature Immunology. 2020; 21: 1119\u20131133.","DOI":"10.1038\/s41590-020-0736-z"},{"key":"ref80","doi-asserted-by":"publisher","unstructured":"Ng LG, Ostuni R, Hidalgo A. Heterogeneity of neutrophils. Nature Reviews. Immunology. 2019; 19: 255\u2013265.","DOI":"10.1038\/s41577-019-0141-8"},{"key":"ref81","doi-asserted-by":"publisher","unstructured":"Jaillon S, Ponzetta A, Di Mitri D, Santoni A, Bonecchi R, Mantovani A. Neutrophil diversity and plasticity in tumour progression and therapy. Nature Reviews. Cancer. 2020; 20: 485\u2013503.","DOI":"10.1038\/s41568-020-0281-y"},{"key":"ref82","doi-asserted-by":"publisher","unstructured":"Manfredi AA, Baldini M, Camera M, Baldissera E, Brambilla M, Peretti G, et al. Anti-TNF\u03b1 agents curb platelet activation in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases. 2016; 75: 1511\u20131520.","DOI":"10.1136\/annrheumdis-2015-208442"},{"key":"ref83","unstructured":"U.S. Food and Drug Administration (FDA). Artificial Intelligence-Enabled Medical Devices. 2026. Available at: https:\/\/www.fda.gov\/medical-devices\/software-medical-device-samd\/artificial-intelligence-enabled-medical-devices Accessed 6 July 2026."},{"key":"ref84","doi-asserted-by":"publisher","unstructured":"Muehlematter UJ, Daniore P, Vokinger KN. Approval of artificial intelligence and machine learning-based medical devices in the USA and Europe (2015-20): a comparative analysis. The Lancet. Digital Health. 2021; 3: e195\u2013e203.","DOI":"10.1016\/S2589-7500(20)30292-2"}],"container-title":["Frontiers in Bioscience-Landmark"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/FBL\/31\/7\/10.31083\/FBL48293","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T07:51:22Z","timestamp":1786607482000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/FBL\/31\/7\/10.31083\/FBL48293"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,27]]},"references-count":84,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026]]}},"alternative-id":["S2768-6701(26)01996-9"],"URL":"https:\/\/doi.org\/10.31083\/fbl48293","relation":{},"ISSN":["2768-6701","2768-6698"],"issn-type":[{"value":"2768-6701","type":"print"},{"value":"2768-6698","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,27]]},"article-number":"48293"}}